<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Following the observation that dopaminergic components are present in <z:mpath ids='MPATH_458'>normal</z:mpath> and malignant B cells, we now provide evidence that they additionally express the functionally related trace <z:chebi fb="39" ids="32952">amine</z:chebi>-associated receptor-1 (TAAR1) </plain></SENT>
<SENT sid="1" pm="."><plain>Immunodetectable TAAR1 was found in lines derived from a broad range of B-cell <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e>; and in tonsillar B cells, particularly when activated </plain></SENT>
<SENT sid="2" pm="."><plain>L3055 Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cells were shown to respond to prototypical TAAR1 <z:chebi fb="4" ids="48705">agonists</z:chebi> in cytotoxicity assays with features of apoptotic <z:hpo ids='HP_0011420'>death</z:hpo> evident; <z:mpath ids='MPATH_458'>normal</z:mpath> B cells were somewhat less sensitive to the <z:chebi fb="4" ids="48705">agonists</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>These data raise the possibility that TAAR1 may have therapeutic relevance to <z:hpo ids='HP_0001909'>leukemia</z:hpo>, <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, and wider B-cell pathologies </plain></SENT>
</text></document>